TP53 and neoplasm: Some authors, such as Lavertu P et al.20, safely state that the co-expression of p53 and Ki-67 markers is associated with a lower time of survival free from disease, including lower time to neoplasia recurrence and/or an appearance of a second early primary site, thus reducing the general survival rate.